Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BAKKAFROST - Settlement completed for the Mandatory Offer for the depositary receipts and outstanding common shares in The Scottish Salmon Company Plc

Reference is made to the announcement from P/F Bakkafrost ("Bakkafrost") on 11 December 2019. Settlement is now completed for the Mandatory Offer for the Depositary Receipts and Common Shares in The Scottish Salmon Company which were not already owned by Bakkafrost. The offer period for the Mandatory Offer expired on 9 December 2019 and during the offer period shareholders representing 24,585,445 shares in The Scottish Salmon Company accepted the offer for their shares. On 11 December 2019 Bakkafrost announced that the settlement for the Mandatory Offer was postponed until today 17

Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer

17 December 2019 18:00 GMT   Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer   ODAC voted that Lynparza demonstrated a clinically meaningful and favourablerisk-benefit profile for patients based on Phase III POLO trial results   AstraZeneca and MSD Inc., Kenilworth, NJ, US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 7 to 5 to recommend Lynparza (olaparib) as a

NOTICE OF EXTRAORDINARY GENERAL MEETING

Evolution Gaming Group AB (publ), 556994-5792, holds an extraordinary general meeting on Thursday 16 January 2020 at 14:00 (CET) on Strandvägen 7A in Stockholm, Sweden. The entrance to the meeting will open at 13:45 (CET).RIGHT TO PARTICIPATE AND NOTICE OF ATTENDANCE Shareholders who wish to attend the general meeting must: · be entered as a shareholder in the share register kept by Euroclear Sweden AB on Friday 10 January 2020; and · give notice of attendance to the company no later than on Friday 10 January 2020. Notice of attendance may be given in writing to Evolution

Össur Celebrates 20 Years as a Publicly Traded Company

President and CEO Jon Sigurdsson Rings Nasdaq Closing Bell on December 16NEW YORK, NY, December 17, 2019 – To mark Össur’s 20[th] anniversary as a publicly traded company, Jon Sigurdsson, the company’s President and CEO, rang the closing bell at the Nasdaq MarketSite in New York’s Times Square as the market hit record highs. Upon its first day of trading on the Iceland Stock Exchange in 1999, Össur (Nasdaq: OSSUR) made history as Iceland’s largest Initial Public Offering (IPO), with more than 8,000 shareholders purchasing shares in the company, corresponding to approximately 3% of

Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Nordic Waterproofing Holding A/S’ shares

In accordance with article 19 of Market Abuse Regulation, Nordic Waterproofing Holding A/S, hereby notifies receipt of information of the following transactions in the company's shares made by persons discharging managerial responsibilities and persons closely associated with them.1 Details of the person discharging managerial responsibilities/person closely associated   a) Name: Nudas Veritas AS 2. Reason for the notification a) Position/Status:  Closely associated to Petter Holth, Head of Nordic Waterproofing Norway b) Initial notification/Amendment: Initial notification 3.

Investor Report

To view this report in PDF, please click on the following link: http://www.rns-pdf.londonstockexchange.com/rns/2267X_1-2019-12-17.pdf        RBC Covered Bond Programme Monthly Investor Report Calculation Date:                                     11/29/2019     This report contains information regarding assets pledged as security (theCover Pool) in respect of the obligations under the Covered Bonds issued underRBC's Global Covered Bond Programme as of the indicated Calculation Date.  Thecomposition of the Cover Pool will change as Loans are added and removed from

Qliro Group comments on the fourth quarter

Nelly, a Qliro Group subsidiary, is expected to reach positive operating result before depreciation for the full year, but negative during the fourth quarter. The company has high inventory levels and has therefore made clearance sales while the cost of sales increased in a declining fashion market. As previously communicated, Qliro Group’s result for the quarter is also impacted by higher costs to make Qliro AB ready for listing in the first half of 2020.“The fashion market has been declining with high campaign activity from many participants in the market. To manage inventory levels, we

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.12.2019

Fiskars Corporation NOTIFICATION 17.12.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 17.12.2019   Date 17.12.2019  Exchange transaction Buy  Share class FSKRS  Amount       1,000  Average price/share 11.4650 EURHighest price/share 11.5400 EURLowest price/share 11.4000 EURTotal price 11,465.00 EUR      The shares held by Fiskars Corporation on 17.12.2019:   FSKRS  402,677     On behalf of Fiskars Corporation

United Bankers Corporation: Acquisition of Own Shares 17.12.2019

United Bankers Corporation NOTIFICATION   17.12.2019 at 18:30   UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 17.12.2019 Date 17.12.2019Exchange transaction BuyShare class UNIAVAmount 200Average price/share 9.0000 EURHighest price/share 9.0000 EURLowest price/share 9.0000 EURTotal price 1,800.00 EUR The shares held by United Bankers Corporation on 17.12.2019: UNIAV 37,901 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti

Höegh LNG : Mandatory notification of trade

Hamilton, Bermuda, 17 December 2019 - Höegh LNG Holdings Ltd. ("Höegh LNG" or the "Company") advises that Sveinung J.S. Støhle, President and CEO of Höegh LNG, purchased 10,000 shares in the Company on 17 December 2019 at an average price of NOK 30.91 per share. Following the above transaction, Sveinung J. S. Støhle, holds 199,392 shares and 335,250 options in Höegh LNG and 15,915 common units and 10,374 Phantom Units in Höegh LNG Partners LP.   * * *

#19-1169 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#19-1168 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Bulletin from the Extraordinary General Meeting in Oncopeptides AB (publ)

Stockholm, Sweden – 17 December 2019 – An Extraordinary General Meeting in Oncopeptides AB (publ) (ONCO) was held today, at Tändstickspalatset in Stockholm. At the Extraordinary General Meeting, the following principal resolutions were passed.· It was resolved, in accordance with the Board of Directors’ proposal, to issue not more than 2,200,000 warrants in order to ensure delivery of shares under the incentive program Co-worker LTIP 2019, adopted by the Annual General Meeting 2019. · It was resolved, in accordance with the Nomination Committee’s proposal, to issue not more than 23,491

Greater Than becomes a Microsoft partner- with joint vision to scale Enerfy solutions globally

Stockholm, December 17; Greater Than, the Swedish Insurtech company providing deep learning AI-based price and risk predictions for automotive and insurance industry, earns a prestigious IP co-sell status as part of Microsoft's partner program with the mission to collaborate on extensive joint sales and go-to-market initiatives.“We are very excited to partner with Greater Than and offer their unique service on our platform. The nature of motor books is changing significantly, driven by higher value at risk, new mobility, sustainability considerations, shift in liability, and increasing

Nomination Committee for SSM’s Annual General Meeting 2020 appointed

The Nomination Committee of SSM Holding AB (publ) is made up of the company’s three largest shareholders as at September 30 as well as the Chairman of the Board of SSM. Weland Holding, which is the company’s third largest shareholder, has declined to be included. For this reason, the fourth largest shareholder in the company is included in the Nomination Committee for the company’s Annual General Meeting 2020. The members of the Nomination Committee are: · Ulf Morelius, appointed by Eurodevelopment AG · Johannes Wingborg, appointed by Länsförsäkringar Fondförvaltning AB ·

BioArctic announces research collaboration with Eisai regarding BAN2401

Stockholm, Sweden, December 17, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today the initiation of a research collaboration with Eisai aimed at further studying the unique profile of the investigational drug candidate BAN2401. The research collaboration with Eisai is in addition to the existing development and commercialization agreement for BAN2401. This new research collaboration is intended to further characterize the unique binding profile of BAN2401. “We welcome the opportunity to join forces with Eisai in this initiative to generate additional knowledge

Update from the Phase I/II trial ReGenerate-1 with Remygen[®] []

The main part of the Phase I/II trial ReGenerate-1 with Remygen[®] in type 1 diabetes patients has started and four patients are already included in the trial. Additional patients are scheduled to be included in December and January. Compilation of metabolic results from the completed safety and dose escalation part of the trial awaits a final experimental analysis and is expected to be announced in early 2020.“The recruitment to the main trial is going well and in light of the interesting findings previously shown with GABA in both preclinical and clinical trials, we look forward to being

Metsä Board Corporation: Disclosure under Chapter 9 Section 5 of the Securities Market Act

Metsä Board Corporation Flagging notification 17 December 2019 at 4:45 pm EETMetsä Board Corporation has received on 17 December 2019 an announcement under Chapter 9, Section 5 of the Securities Markets Act, from Ilmarinen Mutual Pension Company. According to the announcement, the total holdings of shares and votes of Ilmarinen Mutual Pension Company in Metsä Board Corporation has fallen below the 5 percent threshold. The flagging notification is based on a share conversion registered on 17 December 2019 in which 2,271,147 A shares (FI0009000640) owned by Ilmarinen Mutual Pension

Vestas secures 21 MW order from BayWa r.e. for two projects in Australia

News release from Asia PacificSingapore, 17 December 2019 Vestas has secured a 21 MW order with the leading global renewable energy developer, BayWa r.e. for the Diapur and Ferguson wind farms in the Western region of Victoria, Australia. Diapur Wind Farm will feature two V150-4.2 MW turbines, while the Ferguson Wind Farm will comprise three V136-4.2 MW turbines. In addition to the supply and installation of the turbines, the order also features a 25-year AOM 4000 service agreement which aims to maximise uptime and ensure optimised performance of the project. Turbine delivery

SEK 8 million for resource efficiency

This autumn, the Södra Research Foundation called for research projects with a ‘Resource efficiency’ theme. SEK 8 million has now been granted to seven research projects with topics ranging from the core products and processes of the forest industy, to new innovations in the use of forest byproducts.One of the projects being funded is called ‘Resource-efficient chipping of spruce bark-beetle damaged wood for chemical pulp production.’ This project focuses on developing a new drum-chipping technology for the pulping process. “This new technology could lead to higher raw material

Changes in the composition of CapMan Plc’s Shareholders’ Nomination Board

CapMan Plc Stock Exchange Release 17 December 2019 at 4.00 p.m. EET Changes in the composition of CapMan Plc’s Shareholders’ Nomination Board Silvertärnan Ab has nominated Stefan Björkman, CEO of Föreningen Konstsamfundet r.f. to CapMan Plc’s Shareholders’ Nomination Board on 17 December 2019. Patrick Lapveteläinen, Member of the Board of Directors, Mandatum Life Insurance Company Limited, resigned from the Nomination Board as Mandatum Life Insurance Company Limited ceased to be among the ten largest shareholders following a change in holdings announced on 21 November 2019. CapMan

Brighter strengthens IP portfolio with 3 new patents in Sweden and South Korea.

Brighter's IP portfolio has been expanded with 3 new patents - two in Sweden and one in South Korea. The patents are related to AI monitoring of connected medical devices and skin patch technology for measuring different biomarkers. For further information, please contact: Truls Sjöstedt, Executive Chairman of the BoardTelephone: +46 729 99 38 60   Email: truls.sjostedt@brighter.se About Brighter AB (publ) Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key

There are no items matching the current filter
There are no more items matching the current filter
Back to top